After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for TG Therapeutics Inc. (TGTX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.27, or 0.85%, to $31.90. The TG Therapeutics Inc. has recorded 45,278 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted TG Therapeutics to Participate in the Bank of America Securities 2023 Health Care Conference.
<25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $31.63 and fluctuated between $31.81 as its day high and $30.03 as its day low. The current market capitalization of TG Therapeutics Inc. is $5.16B. A total of 2.14 million shares were traded on the day, compared to an average of 4.41M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, TGTX has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 1,070,000 and the disposition of 0 shares. Over the last 12 months, there were 9 BUYs and 1 SELLs from insiders. Insiders purchased 1,372,660 shares during that period but sold 30,000.
In the most recent transaction, Echelard Yann bought 9,000 shares of TGTX for 10.64 per share on Jan 06. After the transaction, the Director now owns 201,848 company shares. In a previous transaction on Jan 04, Charney Laurence N sold 30,000 shares at 11.10 per share. TGTX shares that Director owns now total 234,729.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for TGTX in the last 3 months, the mean price target is $30.50 with high estimates of $42.00 and low estimates of $6.00. In terms of 52-week highs and lows, TGTX has a high of $35.67 and a low of $3.48.
As of this writing, TGTX has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.42. The company reported an EPS of -$0.39 in the last quarter, which was -50.00% lower than expectations of -$0.26.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TGTX’s latest balance sheet shows that the firm has $350.30M in Cash & Short Term Investments as of fiscal 2021. There were $79.05M in debt and $65.38M in liabilities at the time. Its Book Value Per Share was $0.20, while its Total Shareholder’s Equity was $237.15M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TGTX is Buy with a score of 4.13.
